Cohance Lifesciences
COHANCENSE

Cohance Lifesciences

₹444.35-19.60 (4.22%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
443.00
Today’s high
468.35
52 week low
266.70
52 week high
1,038.90
Open price
465.00
Previous close
463.95
Live volume
5,17,907
Lower circuit
371.20
Upper circuit
556.70

Fundamentals

Market Cap
₹17,761Cr
ROE
5.05%
P/E Ratio(TTM)
303.43
EPS(TTM)
1.53
P/B Ratio
4.54
Dividend Yield
0.00%
Industry P/E
37.01
Book Value
102.24
Debt to Equity
0.10
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹435
-29.61%
Profit (Cr)
-₹45.19
-643.80%
-2000250500750
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-23%
3Y CAGR-4%
Profit growthValue
3Y CAGR-16%

About

Cohance Lifesciences Limited is a contract development and manufacturing organization (CDMO) and API manufacturer.;
CEO/MD
Dr V. Prasada Raju
Founded in
2020
NSE symbol
COHANCE

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹22,510.00
-445.00 (1.94%)
L
    H
    29,446.7859.1615.72
    ₹210.24
    -3.95 (1.84%)
    L
      H
      28,510.82--3.49
      ₹1,539.20
      -59.70 (3.73%)
      L
        H
        18,324.73--3.14
        ₹408.65
        +1.40 (0.34%)
        L
          H
          16,433.3774.423.4
          Livesquawk
          Goldman Sachs maintains Buy on Cohance with a ₹500 target, citing weak Q1 in Pharma CDMO and Agrochemicals. Recovery is expected from Q2FY27, driven by commercial deliveries, operational normalization, and strategic expansion.
          Livesquawk
          Cohance Lifesciences reports Q1 consolidated net loss of ₹241M. The loss improved compared to ₹489M in the prior year (YoY).
          2026
          5
          Aug
          Quarterly Result
          Release date
          12
          May
          Quarterly & Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks